APC consultations

HNY APC and its subgroups hold open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by the HNY APC for information or approval, as appropriate.

Consultations typically run for four weeks, and comments are invited from all stakeholders across Humber and North Yorkshire. You can comment on current proposals via the links in the table below.

Title:Information:Feedback:End Date:
HNY Medicines, Formulary Group proposed actions from May 2025On behalf of the HNY Medicines Formulary Group, we now seek comments on the actions proposed at the May 2025 meeting.

This consultation will run for four weeks and closes at 5pm on Thursday 26th June
Feedback form5pm on Thursday 26th June
Low priority medicinesFollowing the May meeting of HNY Medicines Formulary Group, we now seek comments on a draft proposal to align the formulary status of several key areas of low priority prescribing. Topics covered include lidocaine patches, liothyronine and levothyroxine, bath emollients, and more.

This consultation will run for four weeks and closes at 5pm on Thursday 26th June
Feedback form5pm on Thursday 26th June
Formulary alignment – musculoskeletal Following the May meeting of HNY Medicines Formulary Group, we now seek comments on a draft formulary alignment for formulary chapter 10 – musculoskeletal. This document aims to align formulary and RAG statuses from the Humber and NY&Y formularies to reach a single HNY position.

This consultation will run for four weeks and closes at 5pm on Thursday 26th June
Feedback form5pm on Thursday 26th June

Please direct any questions to the secretariat at nuth.hnyapc@nhs.net.